BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6483455)

  • 1. Levels of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity versus arterial hypertension.
    Laterza G; Clemenzia G; Gentile V; Bassano F; Scibinetti F; Russo G
    Panminerva Med; 1984; 26(2):101-3. PubMed ID: 6483455
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy.
    Alderman MH; Melcher L; Drayer DE; Reidenberg MM
    N Engl J Med; 1983 Nov; 309(20):1213-7. PubMed ID: 6633570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early diagnosis of renal ischemia in arterial hypertension by means of urine N-acetyl-beta-D-glucosaminidase (author's transl)].
    García M; Méndez X; Botey A; Pons JM; Revert L
    Med Clin (Barc); 1981 Sep; 77(5):200-4. PubMed ID: 7329141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of urinary N-acetyl-beta-D-glucosaminidase activities in children with arterial hypertension (author's transl)].
    Oberiter V; Kunović B; Bajakić D; Straus B; Puretić Z; Lipovac K
    Lijec Vjesn; 1980 Oct; 102(10):553-5. PubMed ID: 7266220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 9. Clinical study of urinary NAG activity in patients with various kidney diseases].
    Suzuki M; Asano Y
    Rinsho Byori; 1983 Sep; Spec No 56():139-46. PubMed ID: 6663755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme activities in the urine of children with primary and secondary hypertension].
    Zoch-Zwierz W; Winiecka W; Tomaszewska B; Wierciński R
    Wiad Lek; 1992 Jul; 45(13-14):498-502. PubMed ID: 1462566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
    Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K
    Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
    Sano K; Uno E
    Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 3. Preclinical evaluation of the urinary NAG activity and changes in diabetic patients].
    Iimura Y; Shimada I; Ohnuki Y; Kawai T; Sakamoto Y
    Rinsho Byori; 1983 Sep; Spec No 56():79-89. PubMed ID: 6663764
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 12. Fluctuations of urinary NAG activities in postcardiotomy renal tubular impairment].
    Nagahama D; Tabata K; Yasuma F
    Rinsho Byori; 1983 Sep; Spec No 56():168-80. PubMed ID: 6663757
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 7. Preclinical evaluation of urinary NAG activity and its fluctuations in primary glomerulonephritis].
    Soejima A; Nagasawa T
    Rinsho Byori; 1983 Sep; Spec No 56():122-31. PubMed ID: 6663753
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparison between the urinary and serum NAG activity in subjects with chronic nephropathies and essential arterial hypertension].
    Persichetti S; Clemenzia G; Laterza G; Sagliaschi G; Spinelli C; Gallo G; Re M; Fagioli A; Punzo G; Angelitti A
    Minerva Med; 1990 Apr; 81(4):265-70. PubMed ID: 2342652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) during follow-up period and related factors in diabetic patients].
    Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
    Rinsho Byori; 1989 Jan; 37(1):37-42. PubMed ID: 2724580
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases].
    Ishida M; Fujino N; Maeba T; Sugiyama M; Kanazawa T; Owada S; Inoue T; Ozawa S; Amakawa T
    Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 10. Clinical significance of urinary NAG activity in patients with kidney diseases, with special reference to nephrotic syndrome and antibiotic treatment].
    Ishimoto F; Shibazaki T; Murai S; Kodama K; Ohno I; Gomi H
    Rinsho Byori; 1983 Sep; Spec No 56():147-59. PubMed ID: 6663756
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes by amikacin].
    Mozer JL; Gibey R; Henry JC
    C R Seances Soc Biol Fil; 1989; 183(2):166-73. PubMed ID: 2531024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)].
    Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C
    Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on N-acetyl-beta-glucosaminidase (NAG) activity in urine. I. Methodological study and normal values].
    Uno E; Sano K
    Rinsho Byori; 1983 Dec; 31(12):1325-9. PubMed ID: 6676486
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis].
    Ueda K; Kato J; Seki T
    Hinyokika Kiyo; 1984 Jul; 30(7):877-82. PubMed ID: 6391119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.